Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgi Apriamashvili

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Immunology Research|July 1, 2021
CRASH-IT Switch Enables Reversible and Dose-Dependent Control of TCR and CAR T-cell FunctionAli Can Sahillioglu, Mireille Toebes, Georgi Apriamashvili, et al.
Cell Reports. Medicine|June 10, 2022
RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cellsZhengkui Zhang, Xiangjun Kong, Maarten A Ligtenberg, et al.
Cancer Research|February 3, 2021
Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody-Drug Conjugate and Immune Checkpoint BlockadeJulia Boshuizen, Nora Pencheva, Oscar Krijgsman, et al.
Nature Communications|April 9, 2022
Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signalingGeorgi Apriamashvili, David W Vredevoogd, Oscar Krijgsman, et al.
Cell|July 16, 2019
Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity ThresholdDavid W Vredevoogd, Thomas Kuilman, Maarten A Ligtenberg, et al.
Journal for Immunotherapy of Cancer|November 7, 2024
TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunctionDavid W Vredevoogd, Georgi Apriamashvili, Pierre L Levy, et al.
Cancer Cell|March 15, 2024
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitnessChun-Pu Lin, Pierre L Levy, Astrid Alflen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Immunology Research|July 1, 2021
CRASH-IT Switch Enables Reversible and Dose-Dependent Control of TCR and CAR T-cell FunctionAli Can Sahillioglu, Mireille Toebes, Georgi Apriamashvili, et al.
Cell Reports. Medicine|June 10, 2022
RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cellsZhengkui Zhang, Xiangjun Kong, Maarten A Ligtenberg, et al.
Cancer Research|February 3, 2021
Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody-Drug Conjugate and Immune Checkpoint BlockadeJulia Boshuizen, Nora Pencheva, Oscar Krijgsman, et al.
Nature Communications|April 9, 2022
Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signalingGeorgi Apriamashvili, David W Vredevoogd, Oscar Krijgsman, et al.
Cell|July 16, 2019
Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity ThresholdDavid W Vredevoogd, Thomas Kuilman, Maarten A Ligtenberg, et al.
Journal for Immunotherapy of Cancer|November 7, 2024
TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunctionDavid W Vredevoogd, Georgi Apriamashvili, Pierre L Levy, et al.
Cancer Cell|March 15, 2024
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitnessChun-Pu Lin, Pierre L Levy, Astrid Alflen, et al.
Pageof 1